Chicago Innovators: A four-person cohort may seed the biotech industry in Chicago

By Lynnea Domienik
Tests for mutations in BRCA genes that increase the risk of ovarian and breast cancer can help guide treatment and prevention.
Tests for mutations in BRCA genes that increase the risk of ovarian and breast cancer can help guide treatment and prevention. Douglas C. Pizac/AP
Tests for mutations in BRCA genes that increase the risk of ovarian and breast cancer can help guide treatment and prevention.
Tests for mutations in BRCA genes that increase the risk of ovarian and breast cancer can help guide treatment and prevention. Douglas C. Pizac/AP

Chicago Innovators: A four-person cohort may seed the biotech industry in Chicago

By Lynnea Domienik
WBEZ brings you fact-based news and information. Sign up for our newsletters to stay up to date on the stories that matter.

The Chicago Biomedical Consortium is piloting a program to train the city’s next generation of bio-entrepreneurs. The four members of the inaugural cohort were recently announced and begin their fellowship next week.

Reset checks in with the executive director of the group for the latest in our series, “Chicago Innovators.”

GUEST: Michelle Hoffmann, executive director Chicago Biomedical Consortium